ORIGINAL_ARTICLE
Copper sulfate inhibits seizure activity induced by pentylenetetrazole in mice
Background and Objective: Copper is one of the main micronutrients of body which plays a key role as a cofactor in the function of metabolic enzymes. Previous studies have shown that copper sulfate () inhibits long-term potentiation (LTP) in slices of hippocampal CA1 region. Whereas LTP is involved in learning and epilepsy, it seems that copper effects on LTP could be associated with its effects on epilepsy and seizure. Therefore, the aim of this study was to evaluate the effect of on seizure induced by pentylenetetrazole (PTZ). Materials and Methods: The effect of various doses of CuSO4 (10, 50 and 100 mg/kg, i.p.), saline (as a control group) or sodium valproate (50, 150 and 100 mg/kg, i.p.) on seizure parameters induced by PTZ (100 mg/kg i.p.) was evaluated in NMRI mice. Twenty minutes after injection of saline or , PTZ (100 mg/kg) was injected to induce seizures in animals and seizure parameters were recorded. Results: Comparison of the effect of , saline or sodium valproate on seizure parameters such as stage 2 latency, stage 5 latency and stage 5 duration showed that dose-dependently reduced seizure. Conclusion: This study showed that significantly inhibits seizure parameters compared with the saline and sodium valproate.
https://jbcp.shahed.ac.ir/article_37_16906c026c6d7073e8813c7a1ff4710d.pdf
2013-12-01
1
5
Copper sulfate
Seizure
Pentylenetetrazole
Valproic acid
Mohammad Reza
Palizvan
1
Department of Physiology, Faculty of Medicine, Arak University of Medical Sciences.
LEAD_AUTHOR
Abolfazl
Jand
2
Department of Physiology, Faculty of Medicine, Arak University of medical Sciences.
AUTHOR
Mohammad Reza
Taherinejad
3
Department of Physiology, Faculty of Medicine, Arak University of medical Sciences.
AUTHOR
ORIGINAL_ARTICLE
Synthesis and study of anticonvulsant effect of 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4-piperidinol as a new derivative of phencyclidine in PTZ-induced kindling model in male mice
Background and Objective: Epilepsy is a common disease in communities. Since there is no cure for it and current treatments are not effective for every patient, new method for medical treatment of epileptic patients is necessary. As NMDA receptors antagonists are the most prominent anti-epileptic drugs, in this study we synthesized and investigated anti-epileptic effect of a new piperidine derivate 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4-piperidinol as a new NMDA receptors antagonist in chemical kindling model. Materials and Methods: In this study, 48 male mice (NMRI), weighting 25-30 g, were selected and randomly divided into 4 groups (n=12 in each group). 1: PTZ 2: 1-[1-(4-Methoxyphenyl) (Cyclohexyl)] 3: piperidinol and 4: valproic acid (positive control). Chemical kindling was induced by PTZ (35 mg/kg, i.p.) injection 11 times one other days (for 22 days). In challenge dose at day 24, PTZ was applied at 75 mg/kg to the animals. Thirty minutes after PTZ injection, the animals were followed for convulsion scores (0-5). Finally, the mean of convulsion phases, threshold and duration of 2 and 5 phases were considered as data and the statistical analysis was done. Results: Data analysis showed that administration of the new piperidine derivate Methoxy-PCP has a prominent anticonvulsant effect than PCP, especially in reduction of phase 5 duration. Conclusion: The results suggest that administration of the new piperidine derivate, 1-[1-(4-Methoxyphenyl) (Cyclohexyl)] 4-piperidinol could yield a prominent anticonvulsant effect in epilepsy. Regarding changes in conformation of the new drug as a non-competitive antagonist, it may potentially block the NMDA receptors than other piperidine derivates.
https://jbcp.shahed.ac.ir/article_38_0d90a2b8e5b9015fb60589054d8dac0b.pdf
2013-12-01
6
14
Mahdieh
Niknezhad
m_gift_85@yahoo.com
1
Department of Physiology, School of Medicine, Shahed University,Tehran,Iran
AUTHOR
Mohsen
Khalili
najafabady@yahoo.com
2
Department of Physiology, School of Medicine, Shahed University,Tehran,Iran
AUTHOR
Abbas
Ahmadi
abbas_ahmady_3957@yahoo.com
3
Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran.
AUTHOR
ORIGINAL_ARTICLE
Methadone and haloperidol combination effect on the acquisition and expression of morphine tolerance and dependence in male mice
Background and Objective: Today, opioids are used to control and relieve acute and chronic pain. However, the incidence of both tolerance and dependence phenomena for these drugs is a major problem. So, in this study, the combination effect of haloperidol and methadone on the acquisition and expression of morphine dependence and tolerance was examined. Materials and Methods: Ninety-eight mice were randomly divided into groups of acquisition and expression. Each group was divided into seven sub-groups, saline, morphine, methadone, haloperidol, haloperidol + methadone, methadone + haloperidol ratio of 2 to 1, methadone + haloperidol ratio of 1 to 2. All groups were addicted with gradually increasing doses of morphine for 7 consecutive days. All drugs in the acquisition group were injected 30 minutes before morphine injected for 7 days and in the expression group 30 minutes before morphine injected in the eight day (test day). Morphine tolerance was measured by tail immersion test for 30 minutes before and after administration of morphine in test day. To assess dependence, mice were administered with naloxone and withdrawal behaviors were observed for 30 minutes. Results: Chronic morphine injections induced tolerance and dependence in mice. Percentage of MPE as a tolerance index was significantly increased in acquisition and expression groups in drugs combination methadone1+haloperidol2 than morphine ones. Also, in dependence group, a marked decrease was shown in withdrawal behaviors in the combination therapy groups. Conclusion: Our results showed that probably methadone and haloperidol combination treatment, especially at a ratio of 1 to 2, could reduce tolerance and dependence more than single drug treatment in animal groups.
https://jbcp.shahed.ac.ir/article_39_640c7eb3c8f3cf3d4ba150de1fbfeabd.pdf
2013-12-01
15
22
Tolerance
Dependence
Morphine
Methadone
Haloperidol
Iman
Ansari
dransarieman@yahoo.com
1
School of Medicine, Shahed University, Tehran, Iran
LEAD_AUTHOR
Esmat
Yaghoutpoor
2
School of Basic Sciences, Shahed University, Tehran, Iran
AUTHOR
Zahra
Kiasalari
kiasalari@yahoo.com
3
School of Medicine, Shahed University, Tehran, Iran
AUTHOR
Mohsen
Khalili
najafabady@yahoo.com
4
School of Medicine, Shahed University, Tehran, Iran
AUTHOR
ORIGINAL_ARTICLE
The effect of simvastatin in prevention of histological changes of substantia nigra and behavioral abnormalities in an experimental model of Parkinson’s disease in rat
Background and Objective: Parkinson’s disease (PD) is a rather common neurological disorder in elders that is due to degeneration of dopaminergic neurons within mesencephalic substantia nigra pars compacta. With regard to protective and antioxidant effect of simvastatin, this study was conducted to evaluate its neuroprotective effect in an experimental model of PD. Materials and Methods: In this experimental study, male rats (n =40) were divided into 5 groups, i.e. sham-operated, simvastatin20-treated sham-operated, lesioned and simvastatin10 and simvastatin20-treated lesioned groups. The hemi-PD early model was induced by unilateral intrastriatal injection of l of saline-ascorbate; left side). Theg/56-hydroxydopamine (6-OHDA, 12.5 treated sham and lesioned groups received simvastatin i.p. at doses of 10 and 20 mg/kg once a day before surgery for two times at an interval of 24 h. Two weeks after surgery, the animals were tested for rotational behavior by apomorphine for an hour and the number of dopaminergic neurons in the substantia nigra pars compacta (SNC) was counted. Results: Two weeks after surgery, apomorphine caused a significant contralateral turning (PConclusion: Intraperitoneal administration of simvastatin exhibits neuroprotective effect against 6-OHDA toxicity in an experimental model of PD, as was shown by a lower rotational behavior and attenuation of neuronal loss.
https://jbcp.shahed.ac.ir/article_40_eb79c087284df264289dc4aaccaf13f1.pdf
2013-12-01
23
28
Simvastatin
Parkinson’s disease
6-hydroxydopamine
Rotational behavior
Apomorphine
Substantia nigra
Ladan
Habibi-Nikakhlagh
habibi-nikakhlagh@yahoo.com
1
Department of Biology, Payame Noor University,Tehran, Iran.
AUTHOR
Sima
Nasri
nasri@yahoo.com
2
Department of Biology, Payame Noor University,Tehran, Iran.
LEAD_AUTHOR
Mehrdad
Roghani
mroghani@shahed.ac.ir
3
Neurophysiology Research Center, Shahed Univeresity, Tehran, Iran.
AUTHOR
ORIGINAL_ARTICLE
Pathological characteristics of uterus in rats with polycystic ovary
Background and Objective: Uterus of rat with polycystic ovary (PCO) may show pathological features. We provided pathological evidence for the rat uterus with NO-induced PCO. Materials and Methods: Wistar rats (weighing 200-250 g) were kept diestrous to receive L-arginine (50 mg/kg) intraperitoneally (i.p.) for 9 days/once a day. Control group solely received saline (1 ml/kg, 9 days/once per day). At the end of the treatment period, all animals were surgically studied. The rats’ ovaries and uteri were examined biometrically and collected in 10% formalin. The pathological data were collectively determined. Results: The treated ovaries of rats showed polycystic characteristics when compared with the control. The uteri of treated rats also showed pathological changes as compared to those that belonged to the controls. Conclusion: The pathological aspect of rat uterus may be linked with the cystic characteristic of ovary in PCO model. This study provides pathological evidence for uterus of rat with PCO.
https://jbcp.shahed.ac.ir/article_41_b90546790c6cde8dde882a0b69366714.pdf
2013-12-01
29
33
L-Arginine
Polycystic ovary
Pathological evidence
Uterus
Fatemeh
Lakzaei
1
School of Basic Sciences,Shahed University,Tehran,Iran
AUTHOR
Manizheh
Karami
2
Associate Professor, School of Basic Sciences, Shahed University, Tehran, Iran.
LEAD_AUTHOR
Maryam
Darban Fooladi
3
School of Basic Sciences, Shahed University, Tehran, Iran
AUTHOR
Mohammadreza
Jalali Nadoushan
jalalinadooshan@yahoo.com
4
Professor, School of Medicine, Shahed University, Tehran, Iran
AUTHOR
ORIGINAL_ARTICLE
Antidiabetic effect of Teucrium polium aqueous extract in multiple low-dose streptozotocin-induced model of type 1 diabetes in rat
Background and Objective: Teucrium polium (TP) has shown hypoglycemic effect in type 1 diabetes induced by single high dose of the cytotoxic agent streptozotocin (STZ) in rats. This study was conducted to evaluate whether its aqueous extract could have such an effect in multiple low-dose STZ-induced model of type 1 diabetes in rats. Materials and Methods: Male Wistar rats were divided into control, TP-treated control, diabetic, TP-treated diabetic groups. For induction of autoimmune model of type-1 diabetes, streptozotcin (STZ) was administered at a dose of 20 mg/kg/day for 5 days (multiple low-dose; MLD). Aqueous extract of TP was administered at a dose of 100 mg/kg for 3 weeks, started on 4th day post-STZ injection. Serum glucose level was determined before the study and at 2nd and 4th weeks after the study. Results: TP extract-treated rats had a significantly higher weight versus diabetic rats at 4th week (pConclusion: Subchronic TP aqueous extract treatment of rats with autoimmune model of diabetes could attenuate abnormal changes in serm glucose and this may be of potential benefit in patients with type 1 diabetes.
https://jbcp.shahed.ac.ir/article_42_d339a6e4680d3779aff3ed66928d55dd.pdf
2013-12-01
34
38
Zari
Sabet
sabet@yahoo.com
1
Department of Internal Medicine and Endocrinology, School of Medicine, Shahed University, Tehran, Iran.
AUTHOR
Mehrdad
Roghani
mroghani@shahed.ac.ir
2
Department of Internal Medicine and Endocrinology, School of Medicine, Shahed University, Tehran, Iran.
LEAD_AUTHOR
Maryam
Najafi
najafi@yahoo.com
3
School of Medicine, Shahed University, Tehran, Iran.
AUTHOR
Zahra
Maghsoudi
maghsoudi@yahoo.com
4
School of Medicine, Shahed University, Tehran, Iran.
AUTHOR
References
1
1. Imam K. Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Advances in Experimental Medicine and Biology2012; 771: 340-55.
2
2. Gan MJ, Albanese-O'Neill A, Haller MJ. Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research. Current Problems in Pediatric and Adolescent Health Care. 2012; 42: 269-91.
3
3. Glaser NS, Geller DH, Haqq A, Gitelman S, Malloy M; Lawson Wilkins Pediatric Endocrine Society Committee on Drugs and Therapeutics. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population? Pediatric Diabetes 2011; 12: 442-59.
4
4. Yap FY, Kantharidis P, Coughlan MT, Slattery R, Forbes JM. Advanced glycation end products as environmental risk factors for the development of type 1 diabetes. Current Drug Targets 2012; 13: 526-40.
5
5. Baumann B, Salem HH, Boehm BO. Anti-inflammatory therapy in type 1 diabetes. Current Diabetes Reports 2012; 12: 499-509.
6
6. Shehata AM, Quintanilla-Fend L, Bettio S, Singh CB, Ammon HP. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE). Phytomedicine 2011; 18: 1037-44.
7
7. Polakof S. Diabetes therapy: novel patents targeting the glucose-induced insulin secretion. Recent Patents on DNA & Gene Sequences 2010; 4: 1-9.
8
8. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004; 92: 1-21.
9
9. Bahramikia S, Yazdanparast R. Phytochemistry and medicinal properties of Teucrium polium L. (Lamiaceae). Phytotherapy Research 2012; 26: 1581-93.
10
10. Mirghazanfari SM, Keshavarz M, Nabavizadeh F, Soltani N, Kamalinejad M. The effect of "Teucrium polium L." extracts on insulin release from in situ isolated perfused rat pancreas in a newly modified isolation method: the role of Ca2+ and K+ channels. Iranian Biomedical Journal 2010; 14: 178-85.
11
11. Ardestani A, Yazdanparast R, Jamshidi Sh. Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats. Journal of Medicinal Food 2008; 11: 525-32.
12
12. Esmaeili MA, Zohari F, Sadeghi H. Antioxidant and protective effects of major flavonoids from Teucrium polium on beta-cell destruction in a model of streptozotocin-induced diabetes. Planta Medica 2009; 75: 1418-20.
13
13.Shahraki MR, Arab MR, Mirimokaddam E, Palan MJ. The effect of Teucrium polium (Calpoureh) on liver function, serum lipids and glucose in diabetic male rats. Iranian Biomedical Journal 2007; 11:65-8.
14
14. Esmaeili MA, Yazdanparast R. Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets. Journal of Ethnopharmacology 2004; 95: 27-30.
15
ORIGINAL_ARTICLE
The effect of oral consumption of olive leaves on serum glucose level and lipid profile of diabetic rats
Background and Objective: Alleviation of serum glucose level and lipid profile in diabetic patients using herbal medications is of great importance. In the present study, the effect of oral consumption of olive leaves on serum glucose level and lipid profile was investigated. Materials and Methods: Male Wistar rats were divided into four groups including control, control under treatment, diabetic and diabetic under treatment. A single dose of streptozocin (60 mg/kg) was used to induce diabetes in rats. The two groups under treatment were fed with olive leaves powder mixed with the standard food at a ratio of 6.25% for 6 weeks. Serum glucose level and lipids profile were measured before, and at 3rd and 6th weeks after the treatment. Results: In diabetic rats under the treatment with olive leaves, serum glucose level was significantly lower at 6th week as compared to the diabetic rats without treatment (pConclusion: Oral consumption of olive leaves in experimental model of diabetes had hypoglycemic effect and exerts some beneficial changes in lipid profile.
https://jbcp.shahed.ac.ir/article_43_80264f016e0d4cbc57435ea5676804cb.pdf
2013-12-01
39
44
Olive
Diabetes mellitus
Glucose
Lipid
Mohammadhassan
Ghosian Moghaddam
1
Biochemistry Department, Faculty of Medicine, Shahed University, Tehran, Iran.
LEAD_AUTHOR
Yaser
Masomi
2
Faculty of Medicine, Shahed University, Tehran, Iran.
AUTHOR
Mohadese
Razavian
3
Faculty of Medicine, Shahed University, Tehran, Iran.
AUTHOR
1. Thripathi BK, Sivastava AK.Diabetes mellitus: complication and therapeutic. Medical Science Monitor 2006;12:RA130-47
1
2. Wadell PE,Quality of life of patients with diabetes mellitus.an overview of research in primary health care in the Nordic countries. Scandinavian Journal of Primary Health Care 2005;23:68-74
2
3. Shapiro K,Gong WC. Natural products used for diabetes. Journal of the American Pharmaceutical Association 2002;42:217-226
3
4. Zargari A.medical plants. Tehran University Press 1993;2:125-127
4
5. Smova LI,Shode FO,Ramnanan P,Nadar A. Antihypertensive, antiatherosclerotic and Ethnopharmacol. 1996;54:41-46
5
6. Zargary A,medical plants.Tehran University Press 1996; 3: 319-329
6
7. Baluchnejadmojarad T, Roghani M.Garlic extract attenuates time-dependent changes in the reactivity of isolated aorta in streptozotocin-diabetic rats. Life Sciences 2003; 73: 2281-9
7
8. Choi JS, Yokozava T,Oura H, Improvement of hyperglycemia and hyperlipidemia in streptozotocin-diabetic rats by a methanolic extract of prunus diadiana stems and its main component, pruning.Planta medica 1991; 57: 208-211
8
9. Schutz K, Kamerer D, Carle R, Schieber A. Identification and quantification of caffeoylquinic acods and flavonoids from artichoke[ Cynara scolymus L.] heads, juice, and pomace by HPLC-DAD-ESI/MS[n]. Journal of Agricultural and Food Chemistry 2004; 52: 4090-6.
9
10.Yanardag R, Bolkent S, Ozsoy-sacan O, Karabulut-Bulan O.The effect of chard (beta vulgaris L. var. cicla) extract of the kidney tissue, serum urea, and creatinine level of diabetic rats.Phytotherapy Research 2002; 16: 758-761
10
11.Chattopadhyay RR. Possible mechanism of antihyperglycaemic effect of Azardirachata indicaleaf extract . Part IV . General Pharmacology 1996 ; 27: 431-434 .
11
12.Pari L , Saravanan G. Antidiabetic effect of Cogent db , a herbal drug in alloxan-induced diabetes mellitus . Comparative Biochemistry and Physiology Part C 2002 ; 131 : 19-25 .
12
13.Eydi A, Eydi M, Oryan Sh, Flahian F,Darzi R.Hypoglycemic effect of olea extract in diabetic rats. Journal of Medicinal Plants 2004; 12: 36-40.
13
14.Comeyli GH,Miri Moghadam E.The effect of olea extract on glucose and lipid in diabetic rats. Iranian Journal of Endocrinology and Metabolism 2008;4 : 389-394.
14
15.Jamei H, El Feki A, Sayadi S. Antidiabetic and Antioxidant Effects of Hydroxytyrosol and Oluropein from Olive leaves in Alloxan – diabetic Rats. Journal of Agriculture Food Chemistry 2009; 14: 1275 – 84.
15
16.Renis H.Invitro antiviral activity of calcium enelonate. 1969; Antimicrobial Agents and Chemotherapy 9; 167-172.
16
ORIGINAL_ARTICLE
Evaluation of the effect of oral administration of Hab-o Shefa on morphine withdrawal syndrome in rats: a behavioral study
Background and Objective: Traditional Iranian Medicine (TIM) has a long history in the field of diagnosis and treatment of various diseases, particularly addiction. Different therapeutic methods have been recommended in this respect. One of these methods is the replacement of natural narcotics instead of opium. Hab-o Shefa is a natural product of TIM which has been used as an alternative for opium in the treatment of addiction since centuries ago. In this study, the effect of Hab-o Shefa was investigated on behavioral quantities of morphine withdrawal syndrome. Materials and Methods: A total of 30 rats were divided into three groups of ten cases each. The control group received solely morphine at a dosage of 10 mg/kg daily for 8 days by the intraperitoneal route. In the second group, in addition to morphin with the same dosage, methadone at the dosage of 25 mg/kg was daily administered by gavage. Hab-o Shefa at a dosage of 2000 mg/kg through gavage was administered in addition to 10 mg/kg of morphine daily for the third group. Finally and 4 to 24 hours after the last injection of morphine, naloxone was injected i.p. at a dosage of 2.5 mg/kg and the desired withdrawal parameters were evaluated. Results: Considering uncountable parameters, a significant difference was seen when comparing methadone and Hab-o Shefa with placebo in regarding diarrhea symptoms (pConclusion: In summary, Hab-o Shefa better controlled the withdrawal symptoms in comparison with placebo and it also better improved the symptoms of diarrhea and salivation as compared to methadone.
https://jbcp.shahed.ac.ir/article_44_ab94791daeb0d4187ae7cfba85ebd4cb.pdf
2013-12-01
45
49
Hab-o Shefa
Morphine
Traditional Iranian Medicine
Withdrawal symptoms
Seyed Mohammad
Nazari
1
Shahed University, Tehran, Iran.
AUTHOR
Mohsen
Naseri
naserishahed@yahoo.com
2
Clinical Research Center of Traditional Iranian Medicine, Shahed University, Tehran, Iran.
LEAD_AUTHOR
Azarakhsh
Mokri
azarakhshmokri@yahoo.com
3
Psychiatry Department and National Center for Addiction Studies, Tehran, Iran.
AUTHOR
Mohsen
Khalili
najafabady@yahoo.com
4
Neurophysiology Research Center, Shahed University, Tehran, Iran.
AUTHOR
Seyed Abbas
Hasheminejad
5
Traditional Iranian Medicine
AUTHOR
Tayebe
Tavakoli Rad
6
Department of Traditional Iranian Medicine, Shahed University, Tehran, Iran.
AUTHOR
1. Aghili MH. Gharabadin Kabir. 2th edition, Tehran Medical University.2005;899-901.
1
2. Aghili MH. Makhzanol Advieh. 1th edition, Tehran Bavardaran. 2001; 243-55.
2
3. Ansari A. Ekhtiarate Badiei. 1th edition. Tehran Pakhshe Razi. 1992; 308-54.
3
4. Arzani MA. Gharabadin Ghaderi. 2th edition. Tehran Medical University.2009; 18-19.
4
5. Assadi SM, Hafezi M, Mokri A. Razzaghi EM, Ghaeli P. Opioid detoxification using high doses of buprenorphine in 24 hours: A randomized, double blind, controlled clinical trial. Journal of Substance Abuse Treatment. 2004; 27: 75-82.
5
6. Chandler JM, Robie PW, Schoolar JC, Desmond MM. (1975 Mar) The effects of methadone on maternal-fetal interactions in the rat. Journal of Pharmacology Experimental Therapeutics 1975. 192:549-54.
6
7. Ekhtiari H, Mokri A. How can we design a study to evaluate treatment efficacy of a new proposed herbal medicine for opioid dependence. Tehran: Quarterly Addiction. 2012; 7: 42-46.
7
8. Ghafari F. Naseri M. Emaddodin shirazi. formulator of two new formulation of opium(papaversomniferum). Proceeding of International Medicinal and Aromatics. 2010; 9-15.
8
9. Khalili M, Naseri M. Effect of oral datura seeds on control of behavioral withdrawal syndrome in rats. Medical Daneshvar 2008; 16: 25-32.
9
10. Mokri A. Brief overview of the status of drug abuse in Iran.Archives of Iranian Medicine.2002; 5: 190-184.
10
11. Nadery S, Sefatian S, Binazadeh M. (2008) Comprehensive textbook of addiction treatment. 1th Edition. Tehran Iranian National Drug Control Headquarters. 2008; 570-599.
11
12. Naseri M. Clinical pharmacology of Traditional Iranian Medicine. Tehran Monthly Medicinal Journal of Razi. 1994; 12: 6-10.
12
13. Naseri M. Traditional Iranian Medicine and its development using the WHO guidelines. Daneshvar Medical Journal. 2009; 52: 5-71.
13
14. Nazari SM, Naseri M, Ghafari F. Opium and Treatment of Opium Addiction in Traditional Iranian Medicine. Medical History. 2012; 3: 133-150
14
15. Nazem Gahan MA. Ghrarabadin Hakim Aazam. 2th edition. Tehran Medical University .2003; 51-52.
15
16. Shirazi E. Resaleh Fionieh. 1th edition. Tehran Almai.2009; 134-49.
16
17. Tonekaboni M.M. Tohfatolmomenin. 1th edition. Tehran Nashre Shahr 2007; 384-439.
17
18.Vajda JA, Ding MG, Oei TP. Methadone dependence in the rat. Psychopharmacological 1975; 42: 255-61.
18